Evidence map›Paper›PMID 41296429›Full record

ArticleCurrent issues in molecular biology2025

Zhenghao Cai, Mengge Zhang, Qianru Zeng, Yihui Deng, Dingxiang Li

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhenghao CaiCollege of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Mengge ZhangCollege of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Qianru ZengCollege of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Yihui DengCollege of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Dingxiang LiCollege of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.

Funding

Hunan Provincial Natural Science Foundation Innovative Research Group Project 2024JJ1007Hunan Provincial Science and Technology Innovation Team Project 2020RC4050
6 · The paper itself

Abstract

backgroundGastric cancer (GC) remains a leading cause of cancer mortality. E3 ubiquitin ligases, as central regulators of protein stability and signaling within the ubiquitin-proteasome system, have been implicated in tumor progression, but their functional roles in GC are not well established.

methodsWe integrated bioinformatics analysis of TCGA and GEO datasets, in vitro experiments (including cell proliferation, migration, and apoptosis assays), and computational modeling to identify key prognostic factors in GC.

resultsWe established two molecular subtypes (E3GC1/E3GC2) with distinct clinical outcomes and developed a 10-gene prognostic signature. The model showed moderate predictive accuracy (AUC: 0.61-0.71) and was validated externally.

conclusions

Indexed as

E3 ubiquitin ligasegastric cancerMMRN1prognostic signaturetumor microenvironment

Identifiers

PMID41296429
PMCPMC12651045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.